Aaron Cowen’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.93M Hold
121,297
– – 0.09% 61
2026
Q2
$4.51M Buy
+121,297
New +$3.92M 0.08% 67

Other funds holding CLDX

Aaron Cowen's CLDX Position: Q3 2026 in Review

Aaron Cowen held its Celldex Therapeutics (CLDX) position steady in Q3 2026 at 121,297 shares worth $3.93M. The position accounts for 0.09% of the portfolio, ranked #61.

Aaron Cowen first reported a position in CLDX in Q2 2026 and has held it in 2 quarters since. The position peaked at $4.51M in Q2 2026. 249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.

  • Aaron Cowen held 121,297 shares of Celldex Therapeutics worth $3.93M as of Q3 2026.
  • Aaron Cowen left its Celldex Therapeutics share count unchanged in Q3 2026.
  • Celldex Therapeutics made up 0.09% of Aaron Cowen's portfolio in Q3 2026, its #61 holding.
  • Aaron Cowen first reported a position in Celldex Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Aaron Cowen's Celldex Therapeutics position peaked at $4.51M in Q2 2026.
  • 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.

Based on Suvretta Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.